封面
市場調查報告書
商品編碼
1946572

2026年全球多重PCR檢測市場報告

Multiplex PCR Assays Global Market Report 2026

出版日期: | 出版商: The Business Research Company | 英文 250 Pages | 商品交期: 2-10個工作天內

價格
簡介目錄

近年來,多重PCR檢測市場發展迅速,預計將從2025年的17億美元成長到2026年的19.3億美元,複合年成長率達13.4%。過去幾年的成長可能歸因於多種因素,包括感染疾病的增加、分子診斷的日益普及、單重PCR檢測的局限性、對快速診斷結果日益成長的需求以及診斷實驗室基礎設施的擴建。

預計未來幾年多重PCR檢測市場規模將快速成長,到2030年將達到31.7億美元,複合年成長率(CAGR)為13.2%。預測期內的成長可歸因於對疾病早期檢測的日益重視、對綜合診斷解決方案需求的不斷成長、個性化醫療方法的推廣、分子診斷投資的增加以及多重檢測在常規檢測中的應用日益廣泛。預測期內的主要趨勢包括:感染疾病多重檢測的應用日益普及、對高通量診斷檢測的需求不斷成長、症候群檢測組合的使用日益增多、多重PCR在臨床診斷中的應用不斷擴展,以及對具成本效益多靶點檢測方法的日益青睞。

預計對診斷檢測日益成長的需求將推動多重PCR檢測市場的擴張。診斷檢測是指用於確定患者是否存在某種疾病或病症的程序或測試。隨著癌症和糖尿病等慢性疾病的日益普遍,早期準確診斷對於有效管理至關重要。此外,對預防性醫療保健的重視也推動了常規檢測,以便及早發現潛在的健康問題。多重PCR檢測可以同時檢測和分析單一檢體中的多種病原體和遺傳標記,從而提高診斷檢測的效率和全面性。例如,根據英國國家醫療服務體系(NHS)2024年7月發布的公告,2023年的診斷活動已超過疫情前水平,2024年5月的檢測數量比上年同期成長了21%。此外,2024年5月共進行了240萬次診斷檢測。預計對診斷檢測日益成長的需求將推動多重PCR檢測市場的成長。

多重PCR檢測市場的主要企業正致力於整合自動化技術,例如新一代定量PCR (qPCR) 系統,以實現精準靈活的核酸定量,從而應用於先進的臨床診斷和公共衛生領域。新一代qPCR系統能夠同時高通量、精準地偵測多個標靶,有助於提高診斷的準確性和效率。例如,總部位於瑞士的診斷系統解決方案供應商羅氏診斷於2023年11月發布了LightCycler PRO系統。這款新一代qPCR平台具有更佳的溫度均勻性、先進的軟體,並相容於超過200種LightMix Modular和60種CE-IVD檢測方法,能夠以高通量精準地同時檢測多個標靶。此次發布標誌著多重PCR檢測市場正式引入自動化技術,並推動了臨床診斷和公共衛生領域的進步。

目錄

第1章執行摘要

第2章 市場特徵

  • 市場定義和範圍
  • 市場區隔
  • 主要產品和服務概述
  • 全球多重PCR檢測市場:吸引力評分及分析
  • 成長潛力分析、競爭評估、策略契合度評估、風險狀況評估

第3章 市場供應鏈分析

  • 供應鏈與生態系概述
  • 主要原料、資源和供應商清單
  • 主要經銷商和通路合作夥伴名單
  • 主要最終用戶列表

第4章 全球市場趨勢與策略

  • 關鍵技術和未來趨勢
    • 人工智慧和自主智慧
    • 生物技術、基因組學和精準醫學
    • 數位化、雲端運算、巨量資料、網路安全
    • 工業4.0和智慧製造
    • 物聯網 (IoT)、智慧基礎設施和互聯生態系統
  • 主要趨勢
    • 感染疾病多重檢測技術的日益普及
    • 對高通量診斷檢測的需求不斷成長
    • 擴大症候群檢測組合的應用
    • 擴大多重PCR在臨床診斷的應用
    • 人們越來越傾向選擇經濟高效的多標靶檢測方法。

第5章 終端用戶產業市場分析

  • 生物製藥公司
  • 臨床研究所
  • 學術研究機構
  • 診斷中心
  • 標準與檢驗組織

第6章 市場:宏觀經濟情景,包括利率、通貨膨脹、地緣政治、貿易戰和關稅的影響、關稅戰和貿易保護主義對供應鏈的影響,以及新冠疫情對市場的影響

第7章 全球策略分析架構、目前市場規模、市場對比及成長率分析

  • 全球多重PCR檢測市場:PESTEL分析(政治、社會、技術、環境、法律因素、促進因素與限制因素)
  • 全球多重PCR檢測市場規模、對比及成長率分析
  • 全球多重PCR檢測市場表現:規模與成長,2020-2025年
  • 全球多重PCR檢測市場預測:規模與成長,2025-2030年,2035年預測

第8章 全球潛在市場規模(TAM)

第9章 市場細分

  • 按檢測類型
  • 平面檢測、以微珠為基礎的檢測
  • 按產品和服務分類
  • 耗材、設備、軟體和服務
  • 透過使用
  • 疾病診斷、研究與發展及其他用途
  • 最終用戶
  • 生物製藥公司、臨床研究機構、學術研究機構、診斷中心和其他最終用戶
  • 按類型細分:平面測定
  • 基於微陣列的檢測方法,基於DNA晶片的檢測方法
  • 按類型細分:以微珠為基礎的檢測
  • Luminex Xmap 檢測、Magpix 檢測、基於流式細胞技術的輪胎邊緣檢測

第10章 區域與國家分析

  • 全球多重PCR檢測市場:區域分析、預測及成長,2020-2025年、2025-2030年預測、2035年預測
  • 全球多重PCR檢測市場:依國家分類,實際結果與預測,2020-2025年、2025-2030年預測、2035年預測

第11章 亞太市場

第12章:中國市場

第13章 印度市場

第14章 日本市場

第15章:澳洲市場

第16章 印尼市場

第17章 韓國市場

第18章 台灣市場

第19章 東南亞市場

第20章:西歐市場

第21章英國市場

第22章 德國市場

第23章:法國市場

第24章:義大利市場

第25章:西班牙市場

第26章 東歐市場

第27章:俄羅斯市場

第28章 北美市場

第29章:美國市場

第30章:加拿大市場

第31章 南美洲市場

第32章:巴西市場

第33章 中東市場

第34章:非洲市場

第35章 市場監理與投資環境

第36章:競爭格局與公司概況

  • 多重PCR檢測市場:競爭格局及市場佔有率(2024年)
  • 多重PCR檢測市場:公司估值矩陣
  • 多重PCR檢測市場:公司概況
    • F. Hoffmann-La Roche Ltd
    • Thermo Fisher Scientific Inc
    • Abbott Laboratories
    • Danaher Corporation
    • Merck KGaA

第37章:其他領先和創新企業

  • Siemens Healthineers, Becton Dickinson and Company, Agilent Technologies Inc, PerkinElmer Inc, Bio-Rad Laboratories Inc, QIAGEN NV, Tecan Group Ltd, DiaSorin SpA, Bio-Techne Corporation, Promega Corporation, Randox Laboratories Ltd, BioFire Diagnostics Inc, Seegene Inc, NanoString Technologies, Standard BioTools Inc

第38章 全球市場競爭基準分析與儀錶板

第39章 重大併購

第40章:高潛力市場國家、細分市場與策略

  • 2030年多重PCR檢測市場:提供新機會的國家
  • 2030年多重PCR檢測市場:新興細分市場機會
  • 2030年多重PCR檢測市場:成長策略
    • 基於市場趨勢的策略
    • 競爭對手策略

第41章附錄

簡介目錄
Product Code: ME4MMPAC01_G26Q1

Multiplex PCR assays are advanced polymerase chain reaction techniques designed to simultaneously amplify and detect multiple DNA or RNA targets within a single reaction. This approach significantly enhances efficiency by enabling the analysis of various genetic markers or pathogens concurrently, offering comprehensive and cost-effective results.

The primary types of multiplex PCR assays include planar assays and bead-based assays. Planar assays are conducted on flat surfaces or platforms, such as microplates or slides, where arrays of probes are affixed to detect multiple targets in a single sample, facilitating efficient and high-throughput analysis. The product and service offerings encompass consumables, instruments, software, and services applicable to disease diagnosis, research and development, among other areas. End users of these technologies include biopharmaceutical companies, clinical research organizations, academic research institutes, and diagnostic centers.

Tariffs have influenced the multiplex pcr assays market by increasing costs for imported reagents, enzymes, consumables, and analytical instruments. These impacts are most evident in north america and asia-pacific, where laboratories depend heavily on globally sourced molecular diagnostics components. Elevated costs have affected pricing and procurement decisions for diagnostic centers and research institutes. On the positive side, tariffs have encouraged local manufacturing, regional reagent production, and supply chain diversification, strengthening long-term market resilience.

The multiplex pcr assays market research report is one of a series of new reports from The Business Research Company that provides multiplex pcr assays market statistics, including multiplex pcr assays industry global market size, regional shares, competitors with a multiplex pcr assays market share, detailed multiplex pcr assays market segments, market trends and opportunities, and any further data you may need to thrive in the multiplex pcr assays industry. This multiplex pcr assays market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The multiplex pcr assays market size has grown rapidly in recent years. It will grow from $1.7 billion in 2025 to $1.93 billion in 2026 at a compound annual growth rate (CAGR) of 13.4%. The growth in the historic period can be attributed to rising burden of infectious diseases, increasing adoption of molecular diagnostics, limitations of singleplex pcr testing, growing demand for rapid diagnostic results, expansion of diagnostic laboratory infrastructure.

The multiplex pcr assays market size is expected to see rapid growth in the next few years. It will grow to $3.17 billion in 2030 at a compound annual growth rate (CAGR) of 13.2%. The growth in the forecast period can be attributed to growing focus on early disease detection, rising demand for comprehensive diagnostic solutions, expansion of personalized medicine approaches, increasing investments in molecular diagnostics, growing adoption of multiplex assays in routine testing. Major trends in the forecast period include rising adoption of multiplex testing for infectious diseases, increasing demand for high-throughput diagnostic assays, growing use of syndromic testing panels, expansion of multiplex pcr in clinical diagnostics, increasing preference for cost-effective multi-target assays.

The growing demand for diagnostic testing is projected to drive the expansion of the multiplex PCR assay market. Diagnostic testing encompasses procedures or tests used to determine the presence or absence of diseases or conditions in patients. The increasing prevalence of chronic illnesses, such as cancer and diabetes, necessitates early and precise diagnosis for effective management. Furthermore, the emphasis on preventive healthcare promotes routine testing to identify potential health issues early. Multiplex PCR assays enable the simultaneous detection and analysis of multiple pathogens or genetic markers from a single sample, thereby enhancing the efficiency and thoroughness of diagnostic testing. For example, in July 2024, the National Health Service (NHS) reported that diagnostic activity surpassed pre-pandemic levels in 2023, with a 21% rise in tests conducted in May 2024 compared to the previous year. Additionally, 2.4 million diagnostic tests were performed in May 2024. This rising demand for diagnostic testing is expected to drive the growth of the multiplex PCR assay market.

Key players in the multiplex PCR assays market are focusing on integrating automation, such as next-generation quantitative PCR (qPCR) systems, to enhance precise and flexible nucleic acid quantification for advanced clinical diagnostics and public health. Next-generation qPCR systems provide high-throughput, accurate, and simultaneous detection of multiple targets, thus improving diagnostic accuracy and efficiency. For instance, in November 2023, Roche Diagnostics Corporation, a Swiss-based diagnostic system solutions provider, introduced the LightCycler PRO System. This next-generation qPCR platform offers high-throughput, precise, and simultaneous detection of multiple targets, featuring improved temperature uniformity, advanced software, and compatibility with over 200 LightMix Modular and 60 CE-IVD assays. This launch exemplifies the incorporation of automation in the multiplex PCR assays market, advancing clinical diagnostics and public health.

In July 2023, QIAGEN N.V., a Germany-based biotechnology company, partnered with Niba Labs. This partnership aims to advance research in genomic testing and personalized medicine by providing cutting-edge tools, data analysis, and expertise to foster innovation in biotechnology and healthcare. Niba Labs, a US-based biotechnology company, specializes in developing and manufacturing products for genomic research, molecular diagnostics, and personalized medicine.

Major companies operating in the multiplex pcr assays market are F. Hoffmann-La Roche Ltd, Thermo Fisher Scientific Inc, Abbott Laboratories, Danaher Corporation, Merck KGaA, Siemens Healthineers, Becton Dickinson and Company, Agilent Technologies Inc, PerkinElmer Inc, Bio-Rad Laboratories Inc, QIAGEN NV, Tecan Group Ltd, DiaSorin SpA, Bio-Techne Corporation, Promega Corporation, Randox Laboratories Ltd, BioFire Diagnostics Inc, Seegene Inc, NanoString Technologies, Standard BioTools Inc, Agena Bioscience, Fluidigm Corporation

North America was the largest region in the multiplex PCR assays market in 2025. The regions covered in the multiplex pcr assays market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the multiplex pcr assays market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The multiplex PCR assays market consists of sales of reverse transcription multiplex PCR (RT-multiplex PCR), digital multiplex PCR, end-point multiplex PCR, multiplex ligation-dependent probe amplification (MLPA), and probe-based multiplex PCR. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Multiplex PCR Assays Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses multiplex pcr assays market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on end user analysis.
  • Benchmark performance against key competitors based on market share, innovation, and brand strength.
  • Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
  • Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for multiplex pcr assays ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The multiplex pcr assays market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
  • The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
  • The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
  • The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
  • The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
  • The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.

Scope

  • Markets Covered:1) By Assay Type: Planar Assay; Bead Based Assay
  • 2) By Product And Services: Consumables; Instruments; Software And Services
  • 3) By Application: Disease Diagnosis; Research And Development; Other Applications
  • 4) By End User: Biopharmaceutical Companies; Clinical Research Organizations; Academic Research Institutes; Diagnostic Centers; Other End Users
  • Subsegments:
  • 1) By Planar Assay: Microarray-Based Assays; Dna Chip-Based Assays
  • 2) By Bead Based Assay: Luminex Xmap Assays; Magpix Assays; Flow Cytometry-Based Bead Assays
  • Companies Mentioned: F. Hoffmann-La Roche Ltd; Thermo Fisher Scientific Inc; Abbott Laboratories; Danaher Corporation; Merck KGaA; Siemens Healthineers; Becton Dickinson and Company; Agilent Technologies Inc; PerkinElmer Inc; Bio-Rad Laboratories Inc; QIAGEN NV; Tecan Group Ltd; DiaSorin SpA; Bio-Techne Corporation; Promega Corporation; Randox Laboratories Ltd; BioFire Diagnostics Inc; Seegene Inc; NanoString Technologies; Standard BioTools Inc; Agena Bioscience; Fluidigm Corporation
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: Word, PDF or Interactive Report
  • + Excel Dashboard
  • Added Benefits
  • Bi-Annual Data Update
  • Customisation
  • Expert Consultant Support

Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.

Table of Contents

1. Executive Summary

  • 1.1. Key Market Insights (2020-2035)
  • 1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots
  • 1.3. Major Factors Driving the Market
  • 1.4. Top Three Trends Shaping the Market

2. Multiplex PCR Assays Market Characteristics

  • 2.1. Market Definition & Scope
  • 2.2. Market Segmentations
  • 2.3. Overview of Key Products and Services
  • 2.4. Global Multiplex PCR Assays Market Attractiveness Scoring And Analysis
    • 2.4.1. Overview of Market Attractiveness Framework
    • 2.4.2. Quantitative Scoring Methodology
    • 2.4.3. Factor-Wise Evaluation
  • Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation
    • 2.4.4. Market Attractiveness Scoring and Interpretation
    • 2.4.5. Strategic Implications and Recommendations

3. Multiplex PCR Assays Market Supply Chain Analysis

  • 3.1. Overview of the Supply Chain and Ecosystem
  • 3.2. List Of Key Raw Materials, Resources & Suppliers
  • 3.3. List Of Major Distributors and Channel Partners
  • 3.4. List Of Major End Users

4. Global Multiplex PCR Assays Market Trends And Strategies

  • 4.1. Key Technologies & Future Trends
    • 4.1.1 Artificial Intelligence And Autonomous Intelligence
    • 4.1.2 Biotechnology, Genomics And Precision Medicine
    • 4.1.3 Digitalization, Cloud, Big Data And Cybersecurity
    • 4.1.4 Industry 4.0 And Intelligent Manufacturing
    • 4.1.5 Internet of Things (IoT), Smart Infrastructure And Connected Ecosystems
  • 4.2. Major Trends
    • 4.2.1 Rising Adoption Of Multiplex Testing For Infectious Diseases
    • 4.2.2 Increasing Demand For High-Throughput Diagnostic Assays
    • 4.2.3 Growing Use Of Syndromic Testing Panels
    • 4.2.4 Expansion Of Multiplex PCR In Clinical Diagnostics
    • 4.2.5 Increasing Preference For Cost-Effective Multi-Target Assays

5. Multiplex PCR Assays Market Analysis Of End Use Industries

  • 5.1 Biopharmaceutical Companies
  • 5.2 Clinical Research Organizations
  • 5.3 Academic Research Institutes
  • 5.4 Diagnostic Centers
  • 5.5 Reference Laboratories

6. Multiplex PCR Assays Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Multiplex PCR Assays Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

  • 7.1. Global Multiplex PCR Assays PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 7.2. Global Multiplex PCR Assays Market Size, Comparisons And Growth Rate Analysis
  • 7.3. Global Multiplex PCR Assays Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)
  • 7.4. Global Multiplex PCR Assays Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Multiplex PCR Assays Total Addressable Market (TAM) Analysis for the Market

  • 8.1. Definition and Scope of Total Addressable Market (TAM)
  • 8.2. Methodology and Assumptions
  • 8.3. Global Total Addressable Market (TAM) Estimation
  • 8.4. TAM vs. Current Market Size Analysis
  • 8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Multiplex PCR Assays Market Segmentation

  • 9.1. Global Multiplex PCR Assays Market, Segmentation By Assay Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Planar Assay, Bead Based Assay
  • 9.2. Global Multiplex PCR Assays Market, Segmentation By Product And Services, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Consumables, Instruments, Software And Services
  • 9.3. Global Multiplex PCR Assays Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Disease Diagnosis, Research And Development, Other Applications
  • 9.4. Global Multiplex PCR Assays Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Biopharmaceutical Companies, Clinical Research Organizations, Academic Research Institutes, Diagnostic Centers, Other End Users
  • 9.5. Global Multiplex PCR Assays Market, Sub-Segmentation Of Planar Assay, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Microarray-Based Assays, Dna Chip-Based Assays
  • 9.6. Global Multiplex PCR Assays Market, Sub-Segmentation Of Bead Based Assay, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Luminex Xmap Assays, Magpix Assays, Flow Cytometry-Based Bead Assays

10. Multiplex PCR Assays Market Regional And Country Analysis

  • 10.1. Global Multiplex PCR Assays Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • 10.2. Global Multiplex PCR Assays Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Multiplex PCR Assays Market

  • 11.1. Asia-Pacific Multiplex PCR Assays Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 11.2. Asia-Pacific Multiplex PCR Assays Market, Segmentation By Assay Type, Segmentation By Product And Services, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Multiplex PCR Assays Market

  • 12.1. China Multiplex PCR Assays Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 12.2. China Multiplex PCR Assays Market, Segmentation By Assay Type, Segmentation By Product And Services, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Multiplex PCR Assays Market

  • 13.1. India Multiplex PCR Assays Market, Segmentation By Assay Type, Segmentation By Product And Services, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Multiplex PCR Assays Market

  • 14.1. Japan Multiplex PCR Assays Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 14.2. Japan Multiplex PCR Assays Market, Segmentation By Assay Type, Segmentation By Product And Services, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Multiplex PCR Assays Market

  • 15.1. Australia Multiplex PCR Assays Market, Segmentation By Assay Type, Segmentation By Product And Services, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Multiplex PCR Assays Market

  • 16.1. Indonesia Multiplex PCR Assays Market, Segmentation By Assay Type, Segmentation By Product And Services, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Multiplex PCR Assays Market

  • 17.1. South Korea Multiplex PCR Assays Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 17.2. South Korea Multiplex PCR Assays Market, Segmentation By Assay Type, Segmentation By Product And Services, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Multiplex PCR Assays Market

  • 18.1. Taiwan Multiplex PCR Assays Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 18.2. Taiwan Multiplex PCR Assays Market, Segmentation By Assay Type, Segmentation By Product And Services, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Multiplex PCR Assays Market

  • 19.1. South East Asia Multiplex PCR Assays Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 19.2. South East Asia Multiplex PCR Assays Market, Segmentation By Assay Type, Segmentation By Product And Services, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Multiplex PCR Assays Market

  • 20.1. Western Europe Multiplex PCR Assays Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 20.2. Western Europe Multiplex PCR Assays Market, Segmentation By Assay Type, Segmentation By Product And Services, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Multiplex PCR Assays Market

  • 21.1. UK Multiplex PCR Assays Market, Segmentation By Assay Type, Segmentation By Product And Services, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Multiplex PCR Assays Market

  • 22.1. Germany Multiplex PCR Assays Market, Segmentation By Assay Type, Segmentation By Product And Services, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Multiplex PCR Assays Market

  • 23.1. France Multiplex PCR Assays Market, Segmentation By Assay Type, Segmentation By Product And Services, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Multiplex PCR Assays Market

  • 24.1. Italy Multiplex PCR Assays Market, Segmentation By Assay Type, Segmentation By Product And Services, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Multiplex PCR Assays Market

  • 25.1. Spain Multiplex PCR Assays Market, Segmentation By Assay Type, Segmentation By Product And Services, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Multiplex PCR Assays Market

  • 26.1. Eastern Europe Multiplex PCR Assays Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 26.2. Eastern Europe Multiplex PCR Assays Market, Segmentation By Assay Type, Segmentation By Product And Services, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Multiplex PCR Assays Market

  • 27.1. Russia Multiplex PCR Assays Market, Segmentation By Assay Type, Segmentation By Product And Services, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Multiplex PCR Assays Market

  • 28.1. North America Multiplex PCR Assays Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 28.2. North America Multiplex PCR Assays Market, Segmentation By Assay Type, Segmentation By Product And Services, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Multiplex PCR Assays Market

  • 29.1. USA Multiplex PCR Assays Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 29.2. USA Multiplex PCR Assays Market, Segmentation By Assay Type, Segmentation By Product And Services, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Multiplex PCR Assays Market

  • 30.1. Canada Multiplex PCR Assays Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 30.2. Canada Multiplex PCR Assays Market, Segmentation By Assay Type, Segmentation By Product And Services, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Multiplex PCR Assays Market

  • 31.1. South America Multiplex PCR Assays Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 31.2. South America Multiplex PCR Assays Market, Segmentation By Assay Type, Segmentation By Product And Services, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Multiplex PCR Assays Market

  • 32.1. Brazil Multiplex PCR Assays Market, Segmentation By Assay Type, Segmentation By Product And Services, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Multiplex PCR Assays Market

  • 33.1. Middle East Multiplex PCR Assays Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 33.2. Middle East Multiplex PCR Assays Market, Segmentation By Assay Type, Segmentation By Product And Services, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Multiplex PCR Assays Market

  • 34.1. Africa Multiplex PCR Assays Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 34.2. Africa Multiplex PCR Assays Market, Segmentation By Assay Type, Segmentation By Product And Services, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Multiplex PCR Assays Market Regulatory and Investment Landscape

36. Multiplex PCR Assays Market Competitive Landscape And Company Profiles

  • 36.1. Multiplex PCR Assays Market Competitive Landscape And Market Share 2024
    • 36.1.1. Top 10 Companies (Ranked by revenue/share)
  • 36.2. Multiplex PCR Assays Market - Company Scoring Matrix
    • 36.2.1. Market Revenues
    • 36.2.2. Product Innovation Score
    • 36.2.3. Brand Recognition
  • 36.3. Multiplex PCR Assays Market Company Profiles
    • 36.3.1. F. Hoffmann-La Roche Ltd Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.2. Thermo Fisher Scientific Inc Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.3. Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.4. Danaher Corporation Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.5. Merck KGaA Overview, Products and Services, Strategy and Financial Analysis

37. Multiplex PCR Assays Market Other Major And Innovative Companies

  • Siemens Healthineers, Becton Dickinson and Company, Agilent Technologies Inc, PerkinElmer Inc, Bio-Rad Laboratories Inc, QIAGEN NV, Tecan Group Ltd, DiaSorin SpA, Bio-Techne Corporation, Promega Corporation, Randox Laboratories Ltd, BioFire Diagnostics Inc, Seegene Inc, NanoString Technologies, Standard BioTools Inc

38. Global Multiplex PCR Assays Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Multiplex PCR Assays Market

40. Multiplex PCR Assays Market High Potential Countries, Segments and Strategies

  • 40.1 Multiplex PCR Assays Market In 2030 - Countries Offering Most New Opportunities
  • 40.2 Multiplex PCR Assays Market In 2030 - Segments Offering Most New Opportunities
  • 40.3 Multiplex PCR Assays Market In 2030 - Growth Strategies
    • 40.3.1 Market Trend Based Strategies
    • 40.3.2 Competitor Strategies

41. Appendix

  • 41.1. Abbreviations
  • 41.2. Currencies
  • 41.3. Historic And Forecast Inflation Rates
  • 41.4. Research Inquiries
  • 41.5. The Business Research Company
  • 41.6. Copyright And Disclaimer